Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery

Biological Psychiatry

Volumn 45, Issue 3, 1999, Pages 274-277

  Ströhle, Andreas ^a   Romeo, Elena ^b   Hermann, Bettina ^a   Pasini, Augusto ^b   Spalletta, Gianfranco ^b   Di Michele, Flavia ^b   Holsboer, Florian ^a   Rupprecht, Rainer ^a,c  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antidepressants; Depression; Neuroactive steroids; Neurosteroids

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; CORTICOSTERONE DERIVATIVE; NEUROSTEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GABAERGIC SYSTEM; HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; STEROIDOGENESIS;

EID: 17044444204     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00328-X     Document Type: Article

References (22)

1. Campbell J.S., Karavolas H.J. Characterization of the purified pituitary cytosolic NADPH:5α-dihydroprogestrone 3α-hydroxysteroid oxidoreductase. J Steroid Biochem Molec Biol. 37:1990;535-543.
2. Celotti F., Melcangi R.C., Martini L. The 5α-reductase in the brain Molecular aspects and relation to brain function . Front Neuroendocrinol. 13:1992;163-215.
3. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
4. Holsboer F. Neuroendocrinology of mood disorders. Bloom F., Kupfer D.J. Psychopharmacology. The Fourth Generation of Progress. 1995;957-969 Raven Press, New York.
5. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Rev. 17:1996;187-205.
6. Holsboer F, Spengler D, Heuser IJ (1992): The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 93:385-41.
7. Karavolas HJ, Hodges D (1990): Neuroendocrine metabolism of progesterone and related progestin steroids and neuronal activity. Ciba Foundation Symposium. Chichester: John Wiley & Sons, 153:22-55.
8. Krause J.E., Karavolas H.J. Pituitary 5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductases. J Biol Chem. 255:1980;11807-11814.
9. Li X., Bertics P.J., Karavolas H.J. Regional distribution of cytosolic and particulate 5alpha-dihydroprogesterone 3alpha-hydroxysteroid oxidoreductases in female rat brain. J Steroid Biochem Molec Biol. 37:1997;535-543.
10. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
11. Negri-Cesi P., Poletti A., Celotti F. Metabolism of steroids in the brain A new insight in the role of 5α-reductase and aromatase in brain differentiation and functions . J Steroid Biochem Molec Biol. 58:1996;455-466.
12. Patchev V.K., Shoaib M., Holsboer F., Almeida O.F.X. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 62:1994;265-271.
13. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
14. Purdy R.H., Morrow A.L., Moore P.H., Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA. 8:1991;4553-4557.
15. Romeo E., Cheney D.L., Zivkovic I., Costa E., Guidotti A. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia Putative role for allopregnanolone . J Pharmacol Exp Ther. 270:1994;89-96.
16. Romeo E., Ströhle A., di Michele F., Spaletta G., Hermann B., Holsboer F., et al. Effects of antidepressent treatment on neuroactive steroids in major depression. Am J Psychiatry. 155:1998;910-913.
17. Rupprecht R. The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res. 31:1997;297-314.
18. Rupprecht R., Reul J.M.H.M., Trapp T., van Steensel B., Wetzel C., Damm K., et al. Progesterone receptor-mediated effects of neuroactive steroids. Neuron. 11:1993;523-530.
19. Stalla G.K., Giesemann G., Müller O.A., Wood W.G., Scriba P.C. The development of a direct homologous radioimmunoassay for serum cortisol. J Clin Chem Clin Biochem. 19:1981;427-434.
20. Uzunov D.P., Cooper T.B., Costa E., Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA. 93:1996;12599-13604.
21. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA. 95:1998;3239-3244.
22. Vescei P. Glucocorticoids, cortisol, cortisone, corticosterone, compound S and their metabolites. Jaffe B.M., Behrmann H.R. Methods of Hormone Radioimmunoassay. 2nd ed. 1981;767-796 Academic, New York.